HOOKIPA PHARMA INC. Share-based Payment Arrangement, Expense
HOOKIPA PHARMA INC. reported Share-based Payment Arrangement, Expense of -$353.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-05-15
- HOOKIPA PHARMA INC. share-based payment arrangement, expense for the quarter ending 2025-03-31 was -$353.00K.
- HOOKIPA PHARMA INC. share-based payment arrangement, expense for the quarter ending 2024-12-31 was $865.00K, a 107.43% increase year-over-year.
- HOOKIPA PHARMA INC. share-based payment arrangement, expense for the quarter ending 2024-09-30 was $939.00K, a 63.59% increase year-over-year.
- HOOKIPA PHARMA INC. share-based payment arrangement, expense for the quarter ending 2024-06-30 was $459.00K, a 34.05% decline year-over-year.
- HOOKIPA PHARMA INC. share-based payment arrangement, expense for fiscal 2024 was $2.01M, a 14.12% decline from fiscal 2023.
- HOOKIPA PHARMA INC. share-based payment arrangement, expense for fiscal 2023 was $2.35M, a 53.50% decline from fiscal 2022.
- HOOKIPA PHARMA INC. share-based payment arrangement, expense for fiscal 2022 was $5.04M, a 34.03% decline from fiscal 2021.
- HOOKIPA PHARMA INC. share-based payment arrangement, expense for fiscal 2021 was $7.64M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2025-03-31 | -$353.00K 10-Q · filed 2025-05-15 | $512.00K derived: sum of 2 quarters · filed 2025-05-15 | $1.45M derived: sum of 3 quarters · filed 2025-05-15 | $1.91M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | $865.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.80M derived: sum of 2 quarters · filed 2025-02-28 | $2.26M derived: sum of 3 quarters · filed 2025-02-28 | $2.01M 10-K · filed 2025-02-28 |
| 2024-09-30 | $939.00K 10-Q · filed 2024-11-14 | $1.40M derived: sum of 2 quarters · filed 2024-11-14 | $1.15M 10-Q · filed 2024-11-14 | $1.57M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-06-30 | $459.00K 10-Q · filed 2024-08-08 | $210.00K 10-Q · filed 2024-08-08 | $627.00K derived: sum of 3 quarters · filed 2025-05-15 | $1.20M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | -$249.00K 10-Q · filed 2025-05-15 | $168.00K derived: sum of 2 quarters · filed 2025-05-15 | $742.00K derived: sum of 3 quarters · filed 2025-05-15 | $1.44M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $417.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $991.00K derived: sum of 2 quarters · filed 2025-02-28 | $1.69M derived: sum of 3 quarters · filed 2025-02-28 | $2.35M 10-K · filed 2025-02-28 |
| 2023-09-30 | $574.00K 10-Q · filed 2024-11-14 | $1.27M derived: sum of 2 quarters · filed 2024-11-14 | $1.93M 10-Q · filed 2024-11-14 | $2.93M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $696.00K 10-Q · filed 2024-08-08 | $1.35M 10-Q · filed 2024-08-08 | $2.35M derived: sum of 3 quarters · filed 2025-02-28 | $3.40M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $658.00K 10-Q · filed 2024-05-09 | $1.66M derived: sum of 2 quarters · filed 2025-02-28 | $2.70M derived: sum of 3 quarters · filed 2025-02-28 | $4.08M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $2.04M derived: sum of 2 quarters · filed 2025-02-28 | $3.42M derived: sum of 3 quarters · filed 2025-02-28 | $5.04M 10-K · filed 2025-02-28 |
| 2022-09-30 | $1.04M 10-Q · filed 2023-11-09 | $2.42M derived: sum of 2 quarters · filed 2023-11-09 | $4.04M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $1.38M 10-Q · filed 2023-08-10 | $3.00M 10-Q · filed 2023-08-10 | ||
| 2021-12-31 | $7.64M 10-K · filed 2024-03-22 |